Friends of Cancer Research

Analysis

Friends of Cancer Research is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in September 1996, 30 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Friends of Cancer Research reported income of $7.2m and spending of $5.2m, leaving 27% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $5.3m to $7.2m (+36%), an average of +7.9% a year. The sharpest change came in the year to December 2022, when income rose by 23%. Over the whole period it spent 71% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Friends of Cancer Research sits at the 82nd percentile: it is larger than about 82% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 84th percentile within DC. Charities of a similar size with the same main cause include Alameda Health Consortium ($7.2m), McHc-Chicago Hospital Council ($7.2m) and Shodair Childrens Foundation ($7.2m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. Compensation of current officers, directors and key employees was $1.5m (30% of expenses). Other salaries and wages came to $992k. At year end it held assets of $19.7m against liabilities of $3.8m, net assets of $15.8m. It reported 13 employees.